NASDAQ:DARE

Daré Bioscience Stock Insider Trading

Healthcare > Biotechnology

Buy DARE

*Your capital is at risk

$2.05

-0.0900 (-4.21%)

At Close: Jun 03, 2026

Daré Bioscience Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 10.43M and sold 0 DARE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	10.43M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 05, 2024 Buy	Stock Option (right to buy) A-Award	Matz Gregory W Director	Director	40 000 Value: $17.2K
Jun 05, 2024 Buy	Stock Option (right to buy) A-Award	Kelley Susan L. Director	Director	40 000 Value: $17.2K
Jun 05, 2024 Buy	Stock Option (right to buy) A-Award	Rastetter William H Director	Director	40 000 Value: $17.2K
Jun 05, 2024 Buy	Stock Option (right to buy) A-Award	Steele Robin Joan Director	Director	40 000 Value: $17.2K
Jun 05, 2024 Buy	Stock Option (right to buy) A-Award	Grossman Jessica D. Director	Director	40 000 Value: $17.2K
Mar 12, 2024 Buy	Employee Stock Option (right to buy) A-Award	Fair John A Chief Commercial Officer	Officer	290 000 Value: $133.4K
Mar 12, 2024 Buy	Employee Stock Option (right to buy) A-Award	Johnson Sabrina Martucci Chef Executive Officer	Officer	750 000 Value: $345.0K
Mar 12, 2024 Buy	Employee Stock Option (right to buy) A-Award	Haring-layton Mardee Chief Accounting Officer	Officer	290 000 Value: $133.4K
Mar 12, 2024 Buy	Employee Stock Option (right to buy) A-Award	Haring-layton Mardee Chief Accounting Officer	Officer	290 000 Value: $133.4K
Mar 12, 2024 Buy	Employee Stock Option (right to buy) A-Award	Johnson Sabrina Martucci Chef Executive Officer	Officer	750 000 Value: $345.0K
Mar 12, 2024 Buy	Employee Stock Option (right to buy) A-Award	Fair John A Chief Commercial Officer	Officer	290 000 Value: $133.4K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	3 500 Value: $8K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	30 000 Value: $30.3K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	35 000 Value: $26.6K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	25 000 Value: $25.8K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	52 000 Value: $134.7K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	42 000 Value: $66.8K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	80 000 Value: $92.8K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	80 000 Value: $92.8K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	42 000 Value: $66.8K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	52 000 Value: $134.7K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	25 000 Value: $25.8K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	35 000 Value: $26.6K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	30 000 Value: $30.3K
Jan 26, 2024 Buy	Employee Stock Option (right to buy)	Haring-layton Mardee Chief Accounting Officer	Officer	3 500 Value: $8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT DARé BIOSCIENCE, INC.

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its produ...

Read Full Profile Here